Marguerite du Plessis

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

Daniel E. Spratt, Jingbin Zhang, María Santiago‐Jiménez et al. · Journal of Clinical Oncology · 2017 · 213 citations

Medicine, Oncology, Urology +15

Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer

Jason A. Efstathiou, Kent W. Mouw, Ewan A. Gibb et al. · European Urology · 2019 · 151 citations · Full text

Medicine, Oncology, Urology +16

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance

Hyung L. Kim, Ping Li, Huei–Chung Huang et al. · Prostate Cancer and Prostatic Diseases · 2018 · 85 citations · Full text

Medicine, Pathology, Urology +17

Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy

Stephen J. Freedland, Voleak Choeurng, Lauren E. Howard et al. · European Urology · 2016 · 80 citations · Full text

Medicine, Oncology, Urology +17

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer

Matthew R. Cooperberg, Nicholas Erho, June M. Chan et al. · European Urology · 2018 · 78 citations

Medicine, Genetics, Oncology +14